Coya Therapeutics Inc. (COYA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
5.68
0.03 (0.53%)
At close: Jan 15, 2025, 3:59 PM
5.58
-1.76%
After-hours Jan 15, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | 6.00M | n/a | n/a | n/a |
Cost of Revenue | 27.36K | 27.36K | 16.13K | n/a |
Gross Profit | 5.97M | -27.36K | -16.13K | n/a |
Operating Income | -7.90M | -9.81M | -4.87M | -694.77K |
Interest Income | n/a | n/a | n/a | 58.46 |
Pretax Income | -7.26M | -12.24M | -4.89M | -733.20K |
Net Income | -7.99M | -14.68M | -4.87M | -733.20K |
Selling & General & Admin | 7.83M | 4.85M | 2.31M | 445.80K |
Research & Development | 6.04M | 4.94M | 2.54M | 248.97K |
Other Expenses | n/a | 27.36K | 16.13K | n/a |
Operating Expenses | 13.91M | 9.81M | 4.87M | 694.77K |
Interest Expense | n/a | 2.43M | n/a | 38.98K |
Selling & Marketing Expenses | n/a | n/a | n/a | 445.13K |
Cost & Expenses | 13.91M | 9.81M | 4.87M | 694.77K |
Income Tax | 723.85K | 2.43M | -21.48K | -704.65 |
Shares Outstanding (Basic) | 10.16M | 9.95M | 9.68M | 9.68M |
Shares Outstanding (Diluted) | 10.16M | 9.95M | 9.68M | 9.68M |
EPS (Basic) | -0.79 | -1.48 | -0.5 | -0.08 |
EPS (Diluted) | -0.79 | -1.48 | -0.5 | -0.08 |
EBITDA | -7.88M | -12.22M | -4.85M | 10.44K |
Depreciation & Amortization | 27.36K | 27.36K | 16.13K | 704.65K |